Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
life sciences
national blog main
raleigh-durham blog main
4
×
texas blog main
4
×
texas top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
biotech
celgene
clinical trials
drugs
eli lilly
fda
genentech
johnson & johnson
medical device
sanofi
xencor
4d molecular therapeutics
abbvie
acelity
What
known
4
×
bio
drug
new
roundup
acelity
antonio
approved
biopharma
business
cholesterol
companies
company
congress
congressional
crispr
cuts
decades
digital
disease
drugs
epidemic
executives
expensive
faces
fatty
fda
feud
financial
foe
frenzied
group
growing
healing
healthcare
hint
inhibitors
isn’t
jobs
later
Language
unset
Current search:
known
×
photo
×
" texas blog main "
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More